CYP1A2*F Polymorphism contributes at least partially to the Variabilityof Plasma Levels of Dehydroaripiprazole, an active Metabolite of Aripiprazole, in Schizophrenic Patients

Post time 2024-5-7 16:35:47

journal：Drug Metabolism and Bioanalysis Letters

Authors：Takeshi Suzuki; Goyo Nagai; Kazuo Mihara; Yoko Tomori; Shoko Kagawa; Akifumi Nakamura; Kenji Nemoto; Tsuyoshi Kondo

Published date：2023-10-6

DOI：10.2174/0118723128246698230921095141

Article link：http://dx.doi.org/10.2174/0118723128246698230921095141

Article Source：Bentham Science Publishers Ltd.。

Remark：

Post time 2024-5-7 16:35:48

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Bentham] CYP1A2*F Polymorphism contributes at least partially to the Variabilityof Plasma Levels of Dehydroaripiprazole, an active Metabolite of Aripiprazole, in Schizophrenic Patients

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Bentham] CYP1A2*F Polymorphism contributes at least partially to the Variabilityof Plasma Levels of Dehydroaripiprazole, an active Metabolite of Aripiprazole, in Schizophrenic Patients Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Bentham] CYP1A2*F Polymorphism contributes at least partially to the Variabilityof Plasma Levels of Dehydroaripiprazole, an active Metabolite of Aripiprazole, in Schizophrenic Patients